Health Catalyst, Inc. Quarterly Selling and Marketing Expense in USD from Q2 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
Health Catalyst, Inc. quarterly/annual Selling and Marketing Expense history and growth rate from Q2 2018 to Q2 2024.
  • Health Catalyst, Inc. Selling and Marketing Expense for the quarter ending June 30, 2024 was $12.7M, a 22.3% decline year-over-year.
  • Health Catalyst, Inc. Selling and Marketing Expense for the twelve months ending June 30, 2024 was $64.2M, a 20.5% decline year-over-year.
  • Health Catalyst, Inc. annual Selling and Marketing Expense for 2023 was $67.3M, a 23.1% decline from 2022.
  • Health Catalyst, Inc. annual Selling and Marketing Expense for 2022 was $87.5M, a 16.6% increase from 2021.
  • Health Catalyst, Inc. annual Selling and Marketing Expense for 2021 was $75M, a 35.4% increase from 2020.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $64.2M $12.7M -$3.65M -22.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $67.8M $19.1M +$489K +2.63% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $67.3M $17.3M -$3.1M -15.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 $70.4M $15.1M -$10.3M -40.6% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $80.7M $16.4M -$4.53M -21.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $85.3M $18.6M -$2.25M -10.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $87.5M $20.4M -$1.49M -6.82% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 $89M $25.4M +$4.59M +22.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 $84.4M $20.9M +$4.22M +25.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $80.2M $20.8M +$5.17M +33% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $75M $21.9M +$7.07M +47.8% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-22
Q3 2021 $68M $20.8M +$6.18M +42.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $61.8M $16.7M +$4.2M +33.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 $57.6M $15.7M +$2.16M +16% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $55.4M $14.8M +$3.09M +26.4% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 $52.3M $14.6M -$92K -0.63% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $52.4M $12.5M +$2.12M +20.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $50.3M $13.5M +$3.01M +28.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $47.3M $11.7M Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 $14.7M +$950K +6.9% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $10.4M -$1.62M -13.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 $10.5M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q3 2018 $13.8M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 $12M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.